Title : Therapeutic potential of tofogliflozin on nephrotic syndrome secondary to diabetic nephropathy.

Pub. Date : 2017 Jul

PMID : 30279791






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tofogliflozin, a SGLT2 inhibitor, successfully increased urine volume, and reduced body weight, HbA1c, and urinary protein excretion (10.8 to 2.6 g/day) during 24 weeks. 6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol solute carrier family 5 member 2 Homo sapiens